Diagnostic challenges in chikungunya infection: Report of an atypical presentation
|
|
- Jeffry McCarthy
- 6 years ago
- Views:
Transcription
1 6 CCDR 08 January 2015 Volume 41-1 Diagnostic challenges in chikungunya infection: Report of an atypical presentation Craig J 1, Klowak M 2 1, 3, 4*, Boggild AK 1 Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON 2 Faculty of Life Sciences, McMaster University, Toronto, ON 3 Tropical Disease Unit, University Health Network-Toronto General Hospital, Toronto, ON 4 Public Health Ontario Laboratories, Public Health Ontario, Toronto, ON * Corresponding author: andrea.boggild@utoronto.ca Abstract Due in part to increasing global travel, chikungunya fever has emerged as a significant public health concern. With recent outbreaks in Caribbean nations and the first report of locally acquired infection in the United States, there is concern that we may see an increasing number of cases in Canada. As chikungunya fever shares many clinical similarities to other arthropod-borne illnesses such as dengue fever, clinical diagnosis is challenging. We report an atypical presentation of acute chikungunya fever in a man returning from travel to Haiti. Microbiologic diagnosis, treatment, prognosis, and public health implications will aid clinician preparedness for this emerging pathogen. Introduction Chikungunya is a mosquito-borne viral disease increasingly recognized globally as an emerging pathogen. In December 2013, local transmission of chikungunya virus was reported for the first time in the Americas, leading the Public Health Agency of Canada (PHAC) to alert clinicians and public heath personnel to the possibility of chikungunya in returning travellers presenting with fever and polyarthralgia (1). A recent report from the United States Centers for Disease Control and Prevention (CDC) has identified 25 Caribbean countries with reported cases of autochthonous chikungunya infection (2). In this article, we report an atypical case of chikungunya infection in a traveller returning from Haiti, to highlight clinical features shared by chikungunya and other arthropod-borne infections such as dengue, the important diagnostic tools available to clinicians, and to address concerns around global spread of chikungunya infection. Background Chikungunya infection is caused by an alphavirus of the Togaviridae family, and is transmitted primarily by Aedes aegypti mosquitoes, and to a lesser extent, Aedes albopictus (3). Chikungunya virus was first described in Tanzania in 1953 (4) and is considered endemic to parts of West Africa. As of September 2014, there were 88 countries reporting transmission of chikungunya infection, including those in Africa, Europe, Oceania, Asia and, most recently, the Americas (5). The first autochthonous infection with chikungunya in a temperate region occurred in Italy in 2007 with a suspected index case originating in India (6). The suspected vector, Aedes albopictus, was thought to have acquired a genetic mutation due to ecological pressure allowing it to supplement Aedes aegypti as a primary vector (3). As Aedes albopictus is widespread in the southeastern United States, there is growing concern about local transmission in these states. In fact, the first case of locally acquired chikungunya infection in the United States was recently reported in a man from Florida (7). Transmission is not expected to occur in Canada, as the Aedes mosquitoes are not found in this climate region (1). In most cases, the presenting symptom is a disabling symmetrical polyarthralgia associated with fever (8). Common joints involved include the ankles, knees, metacarpophalangeal joints, metatarsal joints, shoulders, elbows, and wrists. In approximately one third of patients, joints can be swollen, although effusive arthritis is rare
2 7 CCDR 08 January 2015 Volume 41-1 (8). Following a period of one to three days, there is often development of a diffuse maculopapular rash, usually sparing the face. Arthralgias typically resolve over weeks; however, in many cases, they can persist for months or even years, often having a significant impact on patient quality of life (9). Clinical diagnosis is challenging as the signs and symptoms of chikungunya overlap with other illnesses, such as parvovirus B19 infection and dengue fever. Microbiologic confirmation is required, and is usually made through detection of immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in serum via enzyme-linked immunosorbent assay (ELISA). IgM antibodies are often detected two to six days after onset of symptoms, whereas IgG antibodies usually appear during the convalescent stage of illness and can persist for years (10). Reverse transcription polymerase chain reaction (RT-PCR), performed on serum, plasma or cerebral spinal fluid (CSF), offers the greatest sensitivity and is available through investigational use by the National Microbiology Laboratory in Winnipeg, Manitoba (11). Our case will highlight some of the diagnostic uncertainty surrounding the diagnosis of chikungunya. Treatment for chikungunya fever is generally supportive, consisting of non-steroidal anti-inflammatory agents, fluids and rest. Corticosteroids are reserved for debilitating arthritis early in the course of acute infection (3). Research into potential monoclonal antibody treatment, antiviral therapy, and vaccinations is ongoing (12, 13). The case A 74-year-old man presented to the emergency department with constipation, abdominal pain, and a new onset diffuse non-desquamating maculopapular rash over the chest, back, arms and legs, following an 11-day trip to Haiti from which he returned one day prior to presentation. His rash was non-painful and non-pruritic. A computed tomography (CT) scan was performed of the abdomen showing small bowel diverticular inflammation and possible perforation into the surrounding fatty tissue. He was admitted to hospital for supportive care, including administration of antibiotics. His perforation was presumed secondary to a previous diagnosis of small bowel diverticular disease complicated by significant constipation. While in Haiti, he had worked as an aid worker in a local health clinic. Prior to travel, he had completed vaccination series for both hepatitis A and B and had been prescribed antimalarial prophylaxis with chloroquine, to which he had been adherent. On day nine of his travel, he awoke with severe diffuse arthralgia affecting both large and small joints in the upper and lower extremities, rigors, and subjective fever. He had no respiratory or gastrointestinal complaints. His arthralgia dramatically improved over a 48-hour period, following which he developed a truncal rash as well as significant constipation, necessitating his presentation to the emergency department. On physical examination in the emergency department, the patient s abdomen was soft and non-tender. There were no joint swellings noted; however, a maculopapular rash was seen over the chest, and the upper and lower extremities. Cardiac, respiratory and neurologic exams were normal. Routine laboratory investigations were performed (Table 1). A significant lymphopenia and thrombocytopenia were noted; chest radiography was also performed on admission and was normal. Table 1: Routine laboratory investigations upon admission to hospital 1 Investigation Value Reference range Hemoglobin 143 g/l g/l Leukocytes 9.9 x 10 9 /L x 10 9 /L Neutrophils 8.6 x 10 9 /L x 10 9 /L Lymphocytes 0.5 x 10 9 /L x 10 9 /L Platelets 108 x 10 9 /L x 10 9 /L AST 36 U/L U/L ALT 18 U/L U/L ALP 94 U/L U/L Bilirubin (total) 11 mmol/l mmol/l Sodium 136 mmol/l mmol/l Potassium 4 mmol/l mmol/l Bicarbonate 22 mmol/l mmol/l Creatinine 79 mmol/l mmol/l
3 8 CCDR 08 January 2015 Volume 41-1 Lactate 1.0 mmol/l mmol/l Urine Cultures Negative N/A 2 Blood Cultures Negative N/A 2 Malaria Rapid Antigen Test 3 Negative N/A 2 1 Abnormal values are in bold N/A = Not applicable 3 Note: Microscopy of Giemsa-stained thin blood smears was also performed. The patient received supportive care, including intravenous crystalloids, and completed a course of antibiotics in hospital. He was discharged with urgent referral to a tropical diseases clinic for evaluation of his presumed travelrelated illness. Dengue virus IgG and IgM antibodies were negative by ELISA. Stool cultures were negative for Salmonella spp., Escherichia coli O157:H7, Campylobacter spp., and Shigella spp. Chikungunya IgM antibody was positive by ELISA supporting a probable diagnosis of acute chikungunya infection. Without follow-up confirmatory testing (such as by plaque reduction neutralization test), the possibility of cross-reactivity with other alphaviruses could not be definitively excluded. His abdominal pain resolved in hospital with supportive care alone, while his arthritis and rash completely resolved over a two-week period. Discussion We present an atypical case of acute infection with chikungunya in a man returning from Haiti, an area of known ongoing intense dengue and chikungunya transmission. Although the patient s initial symptoms included classic findings of symmetric polyarthritis and subsequent maculopapular rash, his clinical course was complicated by significant abdominal pain, constipation, as well as thrombocytopenia features atypical of chikungunya. His dramatic improvement over 48 hours is also unusual as polyarthralgia leading to mobility and dexterity issues will frequently last for weeks to months (3). Although uncommon, other atypical manifestations of chikungunya infection have been reported in the literature. These include neurological features (including encephalitis, seizures, and Guillain-Barre syndrome), cardiovascular features (including myocarditis, heart failure, and ischemic heart disease), renal features (including acute kidney injury), ocular features (including optic neuritis), as well as atypical skin eruptions, ulcerations, and bullae (14). The differential diagnosis of fever and non-effusive polyarthritis is broad. Common bacterial causes include Lyme disease and infective endocarditis. Frequent viral causes include parvovirus B19, hepatitis B and C, rubella, dengue and other alphaviruses, including Mayaro, O nyong-nyong, Ross River, Barmah Forest, Sindbis, and Semliki Forest virus. Non-infectious etiologies include seronegative spondyloarthropathies, rheumatoid arthritis, crystal-induced arthropathies, and post-infectious (reactive) arthritis. Given our patient s epidemiologic risk and presenting features, the most likely infectious etiologies included dengue fever and chikungunya infection, with parvovirus B19 infection less likely. Disease characteristics, clinical features and laboratory data comparing dengue and chikungunya infection are presented in Table 2. Non-infectious causes were deemed unlikely based on the patient s initial fever, rash, and rapid improvement in symptoms. Table 2: Clinical and laboratory features of chikungunya versus dengue fever Clinical and laboratory features Chikungunya Dengue Illness Characteristics (19) Incubation period 3 7 days (range 2 12) 0.03:1 0.25:1 4 7 days (range 3 14) 2:1 10:1 Asymptomatic: Symptomatic ratio Clinical Features (3, 8, 9, 17, 19, 20, 21) Fever Common Common Arthralgia Common Possible Polyarthritis (without effusion) Common Unlikely Myalgia Possible Common Rash Common, often day 1 4 of illness Abdominal Pain Unlikely Possible Common, often day 3 7 of illness
4 9 CCDR 08 January 2015 Volume 41-1 Retro-orbital Pain Unlikely Common Chronic joint pains Common, can last >2 Unlikely years Chronic fatigue Common, can last >2 years Common, up to 3 months Laboratory Neutropenia Possible Common Lymphopenia Common Common Thrombocytopenia Possible Common The brisk improvement in the patient s symptoms without supportive care is atypical for chikungunya infection. Although likely related to an atypical presentation of disease, the therapeutic effect of chloroquine to mitigate the symptoms of chikungunya infection has been suggested by in vitro studies (15). However, this effect has not been confirmed by randomized controlled trials in humans (16); thus, it is unclear whether his chloroquine antimalarial prophylaxis attenuated his symptoms. Constipation leading to abdominal pain is also not a classic feature of chikungunya infection. In a comparative study performed in India, 0 of 131 (0%) patients with acute chikungunya infection reported abdominal pain compared with 22 of 104 (21%) patients with acute dengue (17). However, during an outbreak on Reunion Island, 47% of patients reported gastrointestinal symptoms, although the number with abdominal pain and/or constipation is not reported (8). Given the time course of illness, constipation appears to be associated with this patient s acute chikungunya infection in this case; however, we acknowledge that there may have been two underlying diseases contributing to his symptoms. To explain his constipation and abdominal pain, co-infection with Salmonella spp. enteritis remains a possibility, as this infection is frequently associated with constipation and is endemic to Haiti. Stool cultures in this case were drawn only after administration of antibiotics, which substantially decreases their yield and may have been falsely negative. Conclusion Chikungunya infection is becoming a global concern as countries reporting new transmissions increase. The ability for viral mutation under selective pressure along with growing worldwide travel gives chikungunya significant epidemic potential. Given the varied clinical features at presentation, clinicians need to be vigilant in considering chikungunya infection in patients returning from high-risk countries with fever and polyarthralgia, regardless of other clinical and laboratory features. Although treatment is generally supportive, patient symptoms, including a debilitating arthritis, can persist for years, stressing the importance of patient education in appropriate mosquito bite prevention techniques during travel, including use of DEET- or icaridin-based insect repellants and protective clothing (18). Conflict of interest None Funding None References (1) Deilgat M, Geduld J, Drebot, M. Chikungunya outbreak in the Caribbean CCDR Jan;40(2): (2) Centers for Disease Control and Prevention. Chikungunya in the Caribbean. (3) Thiboutot MM, Kannan S, Kawalekar OU, Shedlock DJ, Khan AS, Sarangan G, et al. Chikungunya: A potentially emerging epidemic? PLoS Negl Trop Dis. 2010;4:e623. (4) Lumsden WH. An epidemic of virus disease in Southern Province, Tanganyika Territory, in II. General description and epidemiology. Trans R Soc Trop Med Hyg Jan;49(1): (5) Centers for Disease Control and Prevention. Geographic distribution Where has chikungunya virus been found?
5 10 CCDR 08 January 2015 Volume 41-1 (6) Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M. Infection with chikungunya virus in Italy: An outbreak in a temperate region. Lancet Dec 1;370(9602): (7) McCarthy M. First case of locally acquired chikungunya is reported in US. BMJ Jul 18;349. (8) Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44: (9) Marimoutou C, Vivier E, Oliver M, Boutin JP, Simon F. Morbidity and impaired quality of life 30 months after chikungunya infection: Comparative cohort of infected and uninfected French military policemen in Reunion Island. Medicine (Baltimore) Jul;91(4): (10) Niedrig M, Zeller H, Schuffenecker I, Drosten C, Emmerich P, Rumer L, et al. International diagnostic accuracy study for the serological detection of chikungunya virus infection. Clin Microbiol Infect. 2009;15: (11) Schwartz KL, Giga A, Boggild AK. Chikungunya fever in Canada: Fever and polyarthritis in a returned traveller. CMAJ Jul 8;186(10): (12) Chang LJ, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: A phase 1 dose-escalation trial. Lancet Dec 6;384(9959): (13) Powers AM. Chikungunya virus control: Is a vaccine on the horizon? Lancet Dec 6;384(9959): (14) Rajapakse S, Rodrigo C, Rajapakse A. Atypical manifestations of chikungunya infection. Trans R Soc Trop Med Hyg Feb;104(2): (15) Khan M, Santhosh SR, Tiwari M, Lakshmana Rao PV, Parida M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol May;82(5): (16) Chopra A, Saluja M, Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol Feb;66(2): (17) Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S. A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg Apr;86(4): (18) Schofield S, Plourde P, for the Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on Personal Protective Measures to Prevent Arthropod Bites. CCDR 2012;38(ACS-3):1 18. (19) Chen LH, Wilson ME. Dengue and chikungunya in travelers. Curr Opin Infect Dis Oct;23(5): (20) Queyriaux B, Simon F, Grandadam M, Michel R, Tolou H, Boutin JP. Clinical burden of chikungunya virus infection. Lancet Infect Dis Jan;8(1):2-3. (21) Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health Nov; 13(11):
Objectives. Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions. Case 1. Dengue Introduction 10/15/2018
Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions Wayne Ghesquiere MD FRCPC Infectious Diseases Consultant Clinical Assistant Prof, UBC Victoria, BC Objectives Discuss common Arbovirus
More informationCHIKUNGUNYA VIRUS INFECTION. Cesar Ponce S. Medical Microbiologist and Parasitologist. Epidemiologist ADC Medical Microbiology Department Director
CHIKUNGUNYA VIRUS INFECTION Cesar Ponce S. Medical Microbiologist and Parasitologist. Epidemiologist ADC Medical Microbiology Department Director Curacao, Aug. 2014 TOPICS: Definition History Epidemiology
More informationPublic Health Image Library. CDC/ Cynthia Goldsmith. Image #
Zika Virus Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar,
More informationFollowing the bite of a mosquito infected with CHIKV, most individuals will
3. CLINICAL 3A. Clinical Presentation of Acute Disease Following the bite of a mosquito infected with CHIKV, most individuals will present with symptomatic disease after an incubation period of 3-7 days
More informationChikungunya Fever: Epidemiology and Clinical Syndrome in Small Infants in Honduras June-July 2015
Chikungunya Fever: Epidemiology and Clinical Syndrome in Small Infants in Honduras June-July 2015 Flora Flowers MD Emergency and Pediatric Critical Care Service Hospital Escuela Universitario 12th Congress
More informationEarly Communications CHIKUNGUNYA OUTBREAK IN THE CARIBBEAN ABSTRACT INTRODUCTION. Deilgat M 1 *, Geduld J 2, Drebot M 3
https://doi.org/10.14745/ccdr.v40i02a01 7 CCDR - January 24, 2014 Volume 40-2 Early Communications CHIKUNGUNYA OUTBREAK IN THE CARIBBEAN 2013-2014 Deilgat M 1 *, Geduld J 2, Drebot M 3 * Corresponding
More informationGeneral Description. Significance
General Description The Zika virus is a member of the Flavivirus family, and is a small, enveloped virus (easy to kill with a hospital disinfectant). Zika virus is an emerging mosquito-borne virus that
More informationFactsheet about Chikungunya
Factsheet about Chikungunya Chikungunya fever is a viral disease transmitted to humans by infected mosquitoes that is characterized by fever, headache, rash, and severe joint and muscle pain. The name
More informationRecent outbreaks of chikungunya in Sri Lanka and the role of Asian Tigers
Recent outbreaks of chikungunya in Sri Lanka and the role of Asian Tigers Introduction CHIK Virus Classification: An ARBOVIRUS Family - Togaviridae Genus Alphavirus ** Enveloped, positive- strand RNA virus.
More informationEuropean Centre for Disease Prevention and Control. Zika virus disease
European Centre for Disease Prevention and Control Zika virus disease Stockholm, 19 February 2016 Background information Zika virus is a member of the Flaviviridae family and transmitted by mosquitoes
More informationGuidance for Investigation and Management of Zika Virus Infection
Guidance for Investigation and Management of Zika Virus Infection Update: February 11, 2016 Public Health Agency of Canada has issued recommendations from the Committee to Advise on Tropical Medicine and
More informationWhat s Lurking out there??????
What s Lurking out there?????? Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene david.warshauer@slh.wisc.edu WISCONSIN STATE LABORATORY OF HYGIENE
More informationZIKA VIRUS. John J. Russell MD May 27, 2016
John J. Russell MD May 27, 2016 HISTORY Discovered 1947 Zika Forest of Uganda in rhesus monkeys, thus the name Found in humans in Africa in 1952 Not considered a public health threat until outbreak in
More informationTMSI Newsletter Taisteal CHIKUNGUNYA AN EMERGING INFECTIOUS RISK FOR TRAVELLERS Chikungunya is a Makonde word and translates as disease that bends up the joints. Chikungunya virus is an alphavirus which
More informationTravel: Chikungunya, Zika,.. New worries
Travel: Chikungunya, Zika,.. New worries McGill Family Physician Refresher Course Dec 6, 2016 Makeda Semret, MD FRCP(C) Infectious Diseases/ Medical Microbiology Disclosures Funding from PHAC/CIHR/GSK/Novartis
More informationChikungunya: Perspectives and Trends Global and in the Americas. Presenter: Dr. Eldonna Boisson PAHO/WHO
Chikungunya: Perspectives and Trends Global and in the Americas Presenter: Dr. Eldonna Boisson PAHO/WHO Outline What is chikungunya Where did chikungunya start? Chikungunya spread - Africa, Asia, Europe,
More informationZika Virus: The Olympics and Beyond
Zika Virus: The Olympics and Beyond Alice Pong, MD Pediatric Infectious Diseases Rady Children s Hospital-San Diego University of California, San Diego Disclosures I have no disclosures to report 1 Objectives
More informationZika Virus. Centers for Disease Control and Prevention
Centers for Disease Control and Prevention Zika Virus Ingrid Rabe Medical Epidemiologist Arboviral Diseases Branch Centers for Disease Control and Prevention February 1, 2016 Zika Virus Single stranded
More informationAnnouncements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone.
1 Announcements Register for the Epi-Tech Trainings: 1. Log-on or Request log-on ID/password: https://tiny.army.mil/r/zb8a/cme 2. Register for Epi-Tech Surveillance Training: https://tiny.army.mil/r/leaid/epitechfy15
More informationSkin and joint manifestations of
Australasian Society for Infectious Diseases Skin and joint manifestations of Arboviruses and Rickettsia Dominic Dwyer Dominic Dwyer Centre for Infectious Diseases and Microbiology ICPMR Westmead Hospital
More informationA RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA
24 th December 2018 A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA BACKGROUND Zika virus infection, which erupted on a large scale in 2015-2016, has infected more than 1.5 million people.
More informationZika Virus and Prevention in Mississippi
Mississippi State Department of Health Mississippi Morbidity Report Volume 32, Number 1 July 2016 Background: Zika Virus and Prevention in Mississippi Key Messages: Zika virus infection during pregnancy
More information10/6/2016. Outline. Zika, Dengue, and Chikungunya Viruses in the Americas Oh My! Some Mosquito-Borne Arboviruses
Zika, Dengue, and Chikungunya Viruses in the Americas Oh My! Geoffrey A. Weinberg, M.D., FAAP, FIDSA, FPIDS Professor of Pediatrics Director, Pediatric HIV Program Division of Pediatric Infectious Diseases
More informationInternational Journal of Pharma and Bio Sciences A STUDY OF CLINCAL PROFILE IN DENGUE CASES ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 A STUDY OF CLINCAL PROFILE IN DENGUE CASES DHANDAPANI E.* 1 AND SUDHA M 2 1 Formerly Professor of Medicine,
More informationClinical Information on West Nile Virus (WNV) Infection
Clinical Information on West Nile Virus (WNV) Infection Introduction In 1999, West Nile Virus (WNV), an Old World flavivirus, producing a spectrum of disease including severe meningoencephalitis, appeared
More informationEverything you ever wanted to know about Zika Virus Disease
Everything you ever wanted to know about Zika Virus Disease (in 14 slides) Jon Temte, MD/PhD University of Wisconsin School of Medicine and Public Health 28 January 2016 Zika Virus mosquito-borne flavivirus
More informationRapid Detection of Chikungunya virus. by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Rapid Detection of Chikungunya virus by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) ABSTRACT Chikungunya is an arthropod-borne viral disease, transmitted mainly by Aedes mosquitoes. The infection
More informationGeographic distribution ZIKV
Shelley M. Wood, RN, BSN, CEN March 16, 2016 Geographic distribution ZIKV 1947 2007 http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2819875/ 1 Current Active Zika transmission WHO declared global health threat
More informationSurveillance Protocol Dengue Fever (Breakbone fever, Dengue Hemorrhagic Fever)
Surveillance Protocol Dengue Fever (Breakbone fever, Dengue Hemorrhagic Fever) Provider Responsibilities 1. Report suspect or confirmed cases of Dengue Fever (DF) or Dengue Hemorrhagic Fever (DHF).to your
More informationCase Classification West Nile Virus Neurological Syndrome (WNNS)
WEST NILE VIRUS Case definition Case Classification West Nile Virus Neurological Syndrome (WNNS) CONFIRMED CASE West Nile Virus Neurological Syndrome (WNNS) Clinical criteria AND at least one of the confirmed
More informationA Case Report of Chikungunya Versus Dengue During an Acute Outbreak of Dengue Fever in The Solomon Islands, 2013
Archives of Immunology and Allergy Volume 1, Issue 1, 2018, PP: 41-45 A Case Report of Chikungunya Versus Dengue During an Acute Outbreak of Dengue Fever in The Solomon Dr. Brian P. Mangum 1, Dr. Tamara
More informationPreparedness plan against Chikungunya and dengue dissemination in mainland France Public Health perspective
Preparedness plan against Chikungunya and dengue dissemination in mainland France Public Health perspective V Bornet annual meeting, Riga 7-9 May 2012 Marie-Claire Paty (Infectious diseases department)
More informationWhat is Zika virus? What are the symptoms and complications of Zika virus infection? Are cases expected in Canada?
What is Zika virus? Zika Virus Update for Healthcare Professionals Updated June 22, 2016; italicized text indicates clarification of wording contained in previous versions. Zika virus is a Flavivirus transmitted
More informationCASE IN... Acute Infectious Diseases. in the Returning Traveller. James Case. Acute Infectious Diseases
in the Returning Traveller Copyright CASE IN... Not for Sale or Commercial Distribution Unauthorised use prohibited. Authorised users can download, display, view and print a single copy for personal use
More informationZika Virus Update for Emergency Care Providers
Zika Virus Update for Emergency Care Providers What is this Zika Virus? Jeff Doerr Epidemiologist Southeastern Idaho Public Health Zika Virus Single stranded RNA virus Genus Flavivirus, Family Flaviviridae
More informationChikungunya Virus Disease Case Investigation, Diagnosis, and Response for Regional and Local Health Departments*
Chikungunya Virus Disease Case Investigation, Diagnosis, and Response for Regional and Local Health Departments* * Based on CDC guidance for State Health Departments distributed July 22, 2014 Scenarios
More informationArbovirus Reports 2015
Arbovirus Reports Arboviruses (Arthropod-borne) are a group of viral infections transmitted by the bite of arthropods, most commonly mosquitoes. Some of these infections are endemic; others may be imported
More informationZika Virus. Robert Wittler, MD
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationZika Virus. Disclosure. Zika Virus 8/26/2016
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationFocus. International #57. Dengue Fever, Chikungunya and the Zika Virus. Chikungunya
Dengue Fever, Chikungunya and the Zika Virus Arboviruses are a group of virus that can be transmitted between animals and humans, and they are common to humans and many vertebrates (mammals, birds, reptiles,
More informationQuarte. FOCUS: Zika. March Volume. Zika Virus. is present. reached. can cause. low, with. in the
COMMUNICABLE DISEASE REPORT Quarte erly Report Volume 33, Number 1 March 2016 FOCUS: Zika Virus, Hepatitis A, Listeriosis Zika Virus Zika Virus (ZikV) has recently been classifiedd as a significant public
More informationMulti-organ Failure from Fulminant Leptospirosis: A Case Report CSIM 2015: Ted Giles Clinical Case Presentation October 17, 2015
Multi-organ Failure from Fulminant Leptospirosis: A Case Report CSIM 2015: Ted Giles Clinical Case Presentation October 17, 2015 Karan Bami, PGY-2, Internal Medicine, University of Ottawa Karan Bami MD,
More informationZika Virus. Maternal & Fetal Effects. John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona
Zika Virus Maternal & Fetal Effects John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona Objective of Presentation Sneeka Peeka at Zika Disclosure I have nothing to disclose
More informationDuane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore AGENDA Other arboviruses with the potential for urban
More information2/16/18 ARBOVIRUSES: CLINICAL FEATURES DISCLOSURES GENERAL ARBOVIRUS CLUES OVERVIEW. I do not have any relevant relationships with industry
ARBOVIRUSES: CLINICAL FEATURES DISCLOSURES Iris Ahronowitz MD, FAAD Assistant Professor of Clinical Dermatology Keck School of Medicine University of Southern California I do not have any relevant relationships
More informationA Global Overview of the Chikungunya Virus Problem
A Global Overview of the Chikungunya Virus Problem Ann M. Powers, Ph.D. Division of Vector-Borne Infectious Diseases Centers for Disease Control and Prevention Chikungunya Virus Family Togaviridae,, genus
More informationAn Introduction to Dengue, Zika and Chikungunya Viruses
An Introduction to Dengue, Zika and Chikungunya Viruses Natalie Marzec, MD, MPH Zoonoses Epidemiologist 2017 Global Health and Disasters Course Objectives Arbovirus Overview Public Health Activities Clinical
More informationZika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016
Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016 This interim guidance is the result of consultation
More informationTown of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus
Aedes Zika Virus Information Sheet Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus The Zika Virus is a mosquito borne illness spread by the Aedes
More informationCarol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016
Carol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016 Michael Hein County Executive Zika virus was first discovered in
More informationZika. Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas
Zika Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas Family Flaviviridae, genus Flavivirus Vectors: Aedes aegypti and Aedes albopictus Maintained in a human-mosquito-human
More informationChikungunya Virus: The Canadian Perspective
Chikungunya Virus: The Canadian Perspective Kimberly Holloway, M.Sc., Zoonotic Diseases Michael Drebot, PhD, Director Zoonotic Diseases and Special Pathogens Environment Canada Quote According to Environment
More informationSeroprevalence and Recent Trends of Dengue in a Rural Area in South India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 36-41 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.005
More informationWest Nile Virus in Maricopa County
West Nile Virus in Maricopa County A Culex quinquefasciatus mosquito on a human finger. Image by James Gathany/ CDC gov/ public domain Maricopa County Department of Public Health Office of Epidemiology
More informationZika Virus. ZIKA VIRUS & PREGNANCY Stephen Champlin, M.D. FLAVIVIRIDAE VIRUS SPECTRUM. Virus family Flaviviridae
ZIKA VIRUS & PREGNANCY Stephen Champlin, M.D. Zika Virus Virus family Flaviviridae Positive sense, single-stranded RNA virus FLAVIVIRIDAE VIRUS SPECTRUM Arbovirus - spread by arthropods to mammals Flaviviridae
More informationWest Nile Virus in Maricopa County
West Nile Virus in Maricopa County Maricopa County Department of Public Health Office of Epidemiology July 21 January 1, 29 December 31, 29 Commentary West Nile virus (WNV) is a mosquito-borne virus that
More informationZika Virus in the Primary Care Setting
Zika Virus in the Primary Care Setting Monica McArthur, MD PhD Assistant Professor of Pediatrics Center for Vaccine Development University of Maryland School of Medicine Maryland Chapter ACP Meeting 17
More informationWest Nile Virus in Maricopa County
West Nile Virus in Maricopa County Maricopa County Department of Public Health Office of Epidemiology July 2009 January 1, 2008 December 31, 2008 Commentary West Nile virus (WNV) is a mosquito-borne virus
More informationZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa
ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa 18 th April 1947; Rhesus macaque (no 766) with fever Filtrable transmissable agent The absence
More informationDengue. (Also Known as Dengue Fever, Dengue Hemorrhagic Fever, and Breakbone Fever)
Dengue (Also Known as Dengue Fever, Dengue Hemorrhagic Fever, and Breakbone Fever) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report
More informationDENGUE FEVER IN SOUTH AFRICA: AN IMPORTED DISEASE
DENGUE FEVER IN SOUTH AFRICA: AN IMPORTED DISEASE Veerle Msimang, Jacqueline Weyer, Chantel le Roux, Pat Leman, Alan Kemp, Janusz Paweska Centre for Emerging and Zoonotic Diseases, NICD Introduction Dengue
More informationZika Outbreak Discussion
Zika Outbreak Discussion May 10, 2016 2016 Zurich Healthcare Customer Symposium Speakers Krishna Lynch Senior Healthcare Risk Consultant Zurich Clayton Shoup Business Director, Workers Compensation Zurich
More information6. SURVEILLANCE AND OUTRBREAK RESPONSE
6. SURVEILLANCE AND OUTRBREAK RESPONSE The main objective of surveillance is to detect, in a timely manner, cases of CHIK in the Americas. Early detection will allow for proper response and characterization
More informationOutbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016
Outbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016 Overview History Distribution Modes of Transmission Symptoms Some Causal
More informationTHE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group
THE ZIKA VIRUS August 3, 2016 Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group sonia@thepanditgroup.com 443-990-1372 www.thepanditgroup.com What Makes Zika Unique? Viral disease (Flavi
More informationZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016
ZIKA VIRUS OUTBREAK JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016 Zika time line 1947: 1 st isolated in rhesus monkey in Zika forest of Uganda 1 12/2013:
More informationARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, AND ZIKA VIRUSES
ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, AND ZIKA VIRUSES 7/31/2017 Arizona Department of Health Services P a g e 1 Arizona Arboviral Handbook for Chikungunya, Dengue, and Zika Viruses OBJECTIVES...
More informationAAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)
AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES) HOUSEKEEPING ITEMS For educational and quality improvement purposes, this ECHO session will be recorded Project ECHO collects participation data
More informationZika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS
Zika: Deet, There It Is Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS Disclosure I have no financial disclosures or conflicts of interest Lessons from Rubella At peak of rubella epidemic
More informationThere is no specific antiviral drug treatment for CHIK. Symptomatic. treatment is recommended after excluding more serious conditions like malaria,
5. CASE MANAGEMENT 5A. Treatment There is no specific antiviral drug treatment for CHIK. Symptomatic treatment is recommended after excluding more serious conditions like malaria, dengue, and bacterial
More informationEmergence du Chikungunya dans les Antilles et caractéristiques virologiques de l épidémie
Emergence du Chikungunya dans les Antilles et caractéristiques virologiques de l épidémie Maquart M, Gallian P, Prat CM, Cassadou S, Flusin O, Huc-Anais P, De Lamballerie X, Leparc- Goffart I Kick-off
More informationAppendix B: Provincial Case Definitions for Reportable Diseases
Ministry of Health and Long-Term Care Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: West Nile Virus Illness Revised March 2017 West Nile Virus Illness
More informationThis memo is intended to provide information to NC clinicians and laboratories regarding diagnosis, management and reporting of Zika virus infection.
May 18, 2016 (replaces version dated March 31, 2016) To: From: North Carolina Health Care Providers and Laboratories Megan Davies, MD, State Epidemiologist Scott Zimmerman, DrPH, MPH, HCLD (ABB), State
More informationMercer MRC A Newsletter for and about our volunteers
Mercer MRC A Newsletter for and about our volunteers May 2017 Volume 1, Issue 5 Brian Hughes, County Executive Marygrace Billek, Director, Dept. of Human Services Lyme Disease Awareness Month May is Lyme
More informationExchange Program. Thailand. Mahidol University. Mahidol-Osaka Center for Infectious Diseases (MOCID) Date: 2013/06/05~2013/07/04
Exchange Program Thailand Mahidol University Mahidol-Osaka Center for Infectious Diseases (MOCID) Date: 2013/06/05~2013/07/04 Kobe University School of Medicine Faculty of Health Science Ueda Shuhei Introduction
More informationSevere Dengue Infection in ICU. Shirish Prayag MD, FCCM Pune, India
Severe Dengue Infection in ICU Shirish Prayag MD, FCCM Pune, India Greetings from India Declaration Honararia from MSD, Astra Zenecea, Fresenius Kabi, Pfizer, Intas, Glenmark for conducting lectures. No
More informationWest Nile Virus in the Region of Peel 2002
HUMAN CASE SURVEILLANCE Introduction Human illness caused by mosquito-borne WNV acquired in Peel occurred for the first time in 2002. In 1999, a Peel resident who had traveled to New York City acquired
More informationEli Schwartz MD,DTMH
DENGUE FEVER in INTERNATIONL TRAVELERS Eli Schwartz MD,DTMH The Center of Geographic Medicine & Tropical Diseases Sheba Medical Center, Tel-Hashomer Sackler Faculty of Medicine, Tel-Aviv univ. ISRAEL World
More informationARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, & ZIKA VIRUSES
ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, & ZIKA VIRUSES 3/3/2016 Arizona Department of Health Services P age 1 Arizona Arboviral Handbook for Chikungunya, Dengue, & Zika Viruses OBJECTIVES...
More informationZika Virus. Division of Infectious Disease Department of Internal Medicine Global Health Program Conference Dora Lebron, MD Alexandra Stang, MD
Zika Virus Division of Infectious Disease Department of Internal Medicine Global Health Program Conference Dora Lebron, MD Alexandra Stang, MD Zika Virus ZIKV is a mosquito-borne ssrna flavivirus from
More informationZIKA VIRUS. Epic and aspects of management
ZIKA VIRUS Epic and aspects of management Classification - Belong to the family Flaviviridae which are mosquitoes borne viruses such as Dengue virus ( DEN V ), West Nile virus ( WN V ), Yellow fever Virus
More informationEDUCATIONAL COMMENTARY EMERGING INFECTIOUS DISEASES WITH GLOBAL IMPACT
Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits under Continuing Education on
More informationZika virus: clinical and epidemiological features
Zika virus: clinical and epidemiological features Dominic Dwyer Medical Virologist, Westmead Hospital Director, ICPMR and Pathology West NSW Health Pathology dominic.dwyer@sydney.edu.au, Zika virus Flavivirus
More informationZIKA VIRUS. Causes, Symptoms, Treatment and Prevention
ZIKA VIRUS Causes, Symptoms, Treatment and Prevention Introduction Zika virus is spread to people through mosquito bites. The most common symptoms of Zika virus disease are fever, rash, joint pain, and
More informationEpidemiology and entomology of the Zika virus outbreak
Epidemiology and entomology of the Zika virus outbreak M A T T H E W B A Y L I S I N S T I T U T E O F I N F E C T I O N A N D G L O B A L H E A L T H U N I V E R S I T Y O F L I V E R P O O L Zika in
More informationWest Nile Virus in Maricopa County
West Nile Virus in Maricopa County Culex larvae found collecting in standing water Image by CDC/James Gathany - License: Public Domain. Maricopa County Department of Public Health Office of Epidemiology
More informationWest Nile Virus. By Frank Riusech
West Nile Virus By Frank Riusech Disease Etiology: West Nile virus(wnv), genus, flavivirus is positive- stranded RNA arbovirus (arthropod- borne), belonging to the Flaviviridae family. Included in this
More informationUpdates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016
Updates in Infectious Diseases Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016 Disclosures No financial relationships or affiliations to disclose Overview Activity Pre-Test
More informationThe problem with TORCH screening
: Beyond TORCHeS TORCH or STORCH-a helpful mnemonic? Toxoplasma Other Rubella CMV HSV (HIV) Syphilis 3 The problem with TORCH screening TORCH-first proposed by Nahmias et.al. (Pediatr Res 1971) Toxo, Rubella,
More informationDr.Saravudh Suvannadabba
Dr.Saravudh Suvannadabba Before Nov 2008; Chikungunya was not a notify disease. Data of Chikungunya cases was not available before 2008 except outbreaks. HISTORY OF CHIKUNGUNYA IN THAILAND 1960: The first
More informationA STUDY ON CHIKUNGUNYA PREVALENCE DURING 2009 IN THE STATE OF ANDHRA PRADESH, SOUTH INDIA
Int. J. Chem. Sci.: 10(1), 2012, 175-181 ISSN 0972-768X www.sadgurupublications.com - A SURVEY REPORT A STUDY ON CHIKUNGUNYA PREVALENCE DURING 2009 IN THE STATE OF ANDHRA PRADESH, SOUTH INDIA S. SIVA PRASAD
More informationZIKA AND MOSQUITO- BORNE ILLNESSES
ZIKA AND MOSQUITO- BORNE ILLNESSES Steven M. Presley, Ph.D. Professor, Environmental Toxicology São Paulo Research Foundation (FAPESP) Week 21 & 22 September 2017 BIOLOGICAL THREAT RESEARCH LABORATORY
More informationVector-Borne Diseases Update: Maricopa County
Vector-Borne Diseases Update: Maricopa County Craig Levy, Epizoologist, Office of Epidemiology WeArePublicHealth.org twitter.com/maricopahealth facebook.com/mcdph Emerging Arboviruses Zika Virus Chikungunya
More informationHot from the Tropics! Fever in the returned traveler workshop. UHN Conference 2015
Hot from the Tropics! Fever in the returned traveler workshop UHN Conference 2015 Case 1: General approach to fever in the returning traveller Exercise 1: Location of travel and pathogens 1. Focus on what
More informationZika Virus Basics. Flaviviridae Flavivirus Disease Vector Vaccine *Dengue (serotypes 1-4) Zika Virus Basics. Zika Virus Transmission Cycle
Zika: Infection,, and Protection Roxanne P. Liles, Ph.D., MLS(ASCP) CM Assistant Professor of Biology Louisiana State University at Alexandria 318-473-6518 rliles@lsua.edu Zika Virus Basics Virion: Enveloped
More informationEmerging vector-borne diseases in the United States: What s next and are we prepared?
Emerging vector-borne diseases in the United States: What s next and are we prepared? Lyle R. Petersen, MD, MPH Director Division of Vector-Borne Diseases Centers for Disease Control and Prevention IOM
More informationWelcome All. Western Australia Oncology Menopause Endometriosis New Mothers
Welcome All Western Australia ZIKA VIRUS What s the latest? Dr Clay Golledge COUNTRIES WITH ONGOING ZIKA CIRCULATION American Samoa Curacao Guyana Nicaragua Tonga Barbados Dominican Republic Haiti Panama
More informationZika Virus Update. Partner Webinar 05/12/2016
Zika Virus Update Partner Webinar 05/12/2016 Today s presenters Patricia Quinlisk, MD, MPH, Medical Director /State Epidemiologist Ann Garvey, DVM, MPH, MA, State Public Health Veterinarian/ Deputy State
More informationChapter. Severe Acute Respiratory Syndrome (SARS) Outbreak in a University Hospital in Hong Kong. Epidemiology-University Hospital Experience
content Chapter Severe Acute Respiratory Syndrome (SARS) Outbreak in a University Hospital in Hong Kong 3 Nelson Lee, Joseph JY Sung Epidemiology-University Hospital Experience Diagnosis of SARS Clinical
More informationCouncil of State and Territorial Epidemiologists Position Statement
04-ID-01 Committee: Title: Infectious Disease Revision of the National Surveillance Case Definition of Diseases Caused by Neurotropic Domestic Arboviruses, Including the Addition to the NNDSS of Non-Neuroinvasive
More information